Purchase Order 75N91020P00910

<p>The National Cancer Institute awarded a purchase order to Nanostring Technologies, Inc., for biological kits valued at $22,867.85 on September 17, 2020, with completion by October 17, 2020. Work is performed in Seattle, Washington. The order is designated as a firm fixed price acquisition in response to the Coronavirus COVID-19 national interest action. No small business set-aside applies.</p>

<p>The National Cancer Institute awarded a purchase order to Nanostring Technologies, Inc. for biological kits valued at $23,204.00, with an award date of May 18, 2021 and ultimate completion date of June 17, 2021. Place of performance is Seattle, Washington. The order is priced on a firm fixed price basis with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Nanostring Technologies, Inc. valued at $22,388.00 for drugs and biologicals, effective September 16, 2020, with completion by October 31, 2020. Place of performance is Seattle, Washington. The order is firm fixed price with no small business set-aside.</p>

<p>The National Cancer Institute issued a purchase order to Nanostring Technologies, Inc. on August 31, 2020, valued at $17,125.00 for drugs and biologicals. Work is performed in Seattle, Washington. The order carries a firm fixed price and was designated under the Coronavirus COVID-19 National Interest Action Code. Ultimate completion is scheduled for September 30, 2020.</p>

<p>The National Cancer Institute awarded a purchase order to Nanostring Technologies, Inc. for biological kits valued at $22,160.00 on April 8, 2021, with ultimate completion on May 7, 2021. Place of performance is Seattle, Washington. The order is for specialized laboratory reagents and consumables to support genomic and molecular analysis research.</p>

<p>The National Cancer Institute awarded a purchase order to Nanostring Technologies, Inc. for laboratory supplies with a ceiling value of $22,240.00, issued on September 21, 2020. Performance occurs in Seattle, Washington. The order covers COVI laboratory supplies in support of coronavirus COVID-19 research, with an ultimate completion date of January 4, 2021. Pricing is firm fixed price on a non-set-aside basis.</p>

<p>The National Cancer Institute awarded a purchase order to Nanostring Technologies, Inc. for $19,000 on July 27, 2019, with completion on July 26, 2020. Performance takes place in Bethesda, Maryland. The order is for firm fixed price commercial items typical of Nanostring's product line—genomic analysis platforms, reagents, assays, or related laboratory consumables supporting molecular and translational research.</p>

<p>The National Cancer Institute issued a purchase order to Nanostring Technologies, Inc. valued at $24,750.00 on January 9, 2020 for laboratory testing and service. Performance occurs in Bethesda, Maryland with an ultimate completion date of February 29, 2020. The order covers specialized laboratory equipment, reagents, assays, or testing services in support of genomic, molecular, and cellular analysis for biomedical research. No set-aside category applies.</p>

The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, awarded a $25,000 purchase order to Nanostring Technologies, Inc. for testing services. The firm fixed price contract will be performed in Seattle, Washington over a four month period concluding in October 2023. The award provides testing services in support of the National Cancer Institute's biomedical research mission. No subcontractors or set aside designations...

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $24,741 purchase order to Nanostring Technologies, Inc. of Seattle, Washington for reagents. The firm fixed price contract runs from August 25, 2023 through September 25, 2023 and supports the NIH NCI's research efforts. As a leading provider of life science tools for translational research and molecular diagnostic products, Nanostring will deliver the requested reagents to aid in the...